"IO Biotech enrols all subjects in Phase II trial of cancer combination therapy" was originally created and published by ...
MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi ...
Irish Examiner on MSN12d
MSD acquires WuXi's vaccine facility in Dundalk for €500mThe Dundalk site was WuXi's first manufacturing investment in Europe and the company’s first investment of this scale outside ...
Pharmaceutical firm MSD has agreed a deal to buy the WuXi Vaccines manufacturing facility in Dundalk, Co Louth as part of its ...
US pharmaceutical group adds eighth Irish manufacturing site to its network as it promises to deliver 1,000 jobs this year ...
MSD has agreed to pay up to $610 million to acquire Caraway Therapeutics, a Cambridge, Massachusetts biotech focusing on neurodegenerative disorders and rare diseases. The big pharma, known as ...
GlobalData on MSN15d
UK MHRA approves MSD’s pulmonary arterial hypertension therapy"UK MHRA approves MSD’s pulmonary arterial hypertension therapy" was originally created and published by Pharmaceutical ...
Irish Independent on MSN12d
MSD buy out WuXi Vaccines’ Dundalk plant in €500m dealThe pharmaceutical firm MSD is buying out the WuXi Vaccines manufacturing plant in Dundalk, in a €500m deal. The American ...
GlobalData on MSN9d
MSD’s HPV vaccine gains China NMPA’s expanded approval for malesChina's National Medical Products Administration has granted expanded approval to MSD's GARDASIL for use in males aged nine to 26 years.
MSD's acquisition of the WuXi Vaccines Dundalk site strengthens the company’s long-standing commitment to Ireland, bringing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback